Ruxolitinib in Combination With Nilotinib in Chronic Myeloid Leukemia (CML) Patients

NCT01702064 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Chronic Phase Chronic Myeloid Leukemia

Interventions

DRUG: Nilotinib
DRUG: Ruxolitinib

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]